Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease. / Wagnerberger, Sabine; Schäfer, Christian; Bode, Christiane; Parlesak, Alexandr.

I: Alcohol, Bind 38, Nr. 1, 2006, s. 37-43.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Wagnerberger, S, Schäfer, C, Bode, C & Parlesak, A 2006, 'Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease', Alcohol, bind 38, nr. 1, s. 37-43. https://doi.org/10.1016/j.alcohol.2006.03.007

APA

Wagnerberger, S., Schäfer, C., Bode, C., & Parlesak, A. (2006). Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease. Alcohol, 38(1), 37-43. https://doi.org/10.1016/j.alcohol.2006.03.007

Vancouver

Wagnerberger S, Schäfer C, Bode C, Parlesak A. Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease. Alcohol. 2006;38(1):37-43. https://doi.org/10.1016/j.alcohol.2006.03.007

Author

Wagnerberger, Sabine ; Schäfer, Christian ; Bode, Christiane ; Parlesak, Alexandr. / Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease. I: Alcohol. 2006 ; Bind 38, Nr. 1. s. 37-43.

Bibtex

@article{3dded0c850584a26a4ee8dd072afc9d9,
title = "Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease",
abstract = "Impaired metabolism of retinol has been shown to occur in alcohol-induced liver disease (ALD). The purpose of the present study was to investigate the saturation of retinol-binding protein (RBP) in 6 patients with different stages of ALD. Hospitalized alcohol consumers (n = 118) with different stages of ALD (ALD1: mild stage of liver damage; ALD2: moderately severe changes of the liver with signs of hepatic inflammation; ALD3: severely impaired liver function) and 45 healthy control subjects were nutritionally assessed, and retinol and RBP content was measured in plasma by high-performance liquid chromatography and enzyme-linked immunosorbent assay methods, respectively. No differences were noted in daily retinol intake, but subjects with ALD had significantly lower concentrations of retinol in plasma (ALD1: 1.81 ± 0.17 μmol/l [mean ± S.E.M.]; ALD2: 1.95 ± 0.24 μmol/l; ALD3: 0.67 ± 0.13 μmol/l) compared to controls (2.76 ± 0.19 μmol/l). Subjects of group ALD2 had significantly higher plasma RBP levels than controls (P < .05) and patients with ALD1 (P < .05) and ALD3 (P < .001). The relative saturation of RBP with retinol decreased with severity of ALD (controls: 76.8 ± 5.0%; ALD1: 55.8 ± 6.5%; ALD2: 43.5 ± 6.2%; ALD3: 29.0 ± 5.1%). The present study indicates that plasma concentrations of retinol and RBP per se do not correlate to severity of ALD, but rather that the retinol/RBP ratio links to the severity of alcohol-induced liver damage. From these results, a reduced availability of retinol in the periphery due to an altered saturation of RBP can be concluded.",
keywords = "Alcohol-induced liver disease, Retinol, Retinol-binding protein",
author = "Sabine Wagnerberger and Christian Sch{\"a}fer and Christiane Bode and Alexandr Parlesak",
note = "(Ekstern)",
year = "2006",
doi = "10.1016/j.alcohol.2006.03.007",
language = "English",
volume = "38",
pages = "37--43",
journal = "Alcohol",
issn = "0741-8329",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease

AU - Wagnerberger, Sabine

AU - Schäfer, Christian

AU - Bode, Christiane

AU - Parlesak, Alexandr

N1 - (Ekstern)

PY - 2006

Y1 - 2006

N2 - Impaired metabolism of retinol has been shown to occur in alcohol-induced liver disease (ALD). The purpose of the present study was to investigate the saturation of retinol-binding protein (RBP) in 6 patients with different stages of ALD. Hospitalized alcohol consumers (n = 118) with different stages of ALD (ALD1: mild stage of liver damage; ALD2: moderately severe changes of the liver with signs of hepatic inflammation; ALD3: severely impaired liver function) and 45 healthy control subjects were nutritionally assessed, and retinol and RBP content was measured in plasma by high-performance liquid chromatography and enzyme-linked immunosorbent assay methods, respectively. No differences were noted in daily retinol intake, but subjects with ALD had significantly lower concentrations of retinol in plasma (ALD1: 1.81 ± 0.17 μmol/l [mean ± S.E.M.]; ALD2: 1.95 ± 0.24 μmol/l; ALD3: 0.67 ± 0.13 μmol/l) compared to controls (2.76 ± 0.19 μmol/l). Subjects of group ALD2 had significantly higher plasma RBP levels than controls (P < .05) and patients with ALD1 (P < .05) and ALD3 (P < .001). The relative saturation of RBP with retinol decreased with severity of ALD (controls: 76.8 ± 5.0%; ALD1: 55.8 ± 6.5%; ALD2: 43.5 ± 6.2%; ALD3: 29.0 ± 5.1%). The present study indicates that plasma concentrations of retinol and RBP per se do not correlate to severity of ALD, but rather that the retinol/RBP ratio links to the severity of alcohol-induced liver damage. From these results, a reduced availability of retinol in the periphery due to an altered saturation of RBP can be concluded.

AB - Impaired metabolism of retinol has been shown to occur in alcohol-induced liver disease (ALD). The purpose of the present study was to investigate the saturation of retinol-binding protein (RBP) in 6 patients with different stages of ALD. Hospitalized alcohol consumers (n = 118) with different stages of ALD (ALD1: mild stage of liver damage; ALD2: moderately severe changes of the liver with signs of hepatic inflammation; ALD3: severely impaired liver function) and 45 healthy control subjects were nutritionally assessed, and retinol and RBP content was measured in plasma by high-performance liquid chromatography and enzyme-linked immunosorbent assay methods, respectively. No differences were noted in daily retinol intake, but subjects with ALD had significantly lower concentrations of retinol in plasma (ALD1: 1.81 ± 0.17 μmol/l [mean ± S.E.M.]; ALD2: 1.95 ± 0.24 μmol/l; ALD3: 0.67 ± 0.13 μmol/l) compared to controls (2.76 ± 0.19 μmol/l). Subjects of group ALD2 had significantly higher plasma RBP levels than controls (P < .05) and patients with ALD1 (P < .05) and ALD3 (P < .001). The relative saturation of RBP with retinol decreased with severity of ALD (controls: 76.8 ± 5.0%; ALD1: 55.8 ± 6.5%; ALD2: 43.5 ± 6.2%; ALD3: 29.0 ± 5.1%). The present study indicates that plasma concentrations of retinol and RBP per se do not correlate to severity of ALD, but rather that the retinol/RBP ratio links to the severity of alcohol-induced liver damage. From these results, a reduced availability of retinol in the periphery due to an altered saturation of RBP can be concluded.

KW - Alcohol-induced liver disease

KW - Retinol

KW - Retinol-binding protein

U2 - 10.1016/j.alcohol.2006.03.007

DO - 10.1016/j.alcohol.2006.03.007

M3 - Journal article

C2 - 16762690

AN - SCOPUS:33744523596

VL - 38

SP - 37

EP - 43

JO - Alcohol

JF - Alcohol

SN - 0741-8329

IS - 1

ER -

ID: 322185311